Form 4: VolitionRx Officer's Stock Withholding for Taxes

VolitionRx General Counsel Nicholas Plummer's Form 4 filing details the disposition of 4,451 shares to cover tax obligations on restricted stock units.

Summary

• Nicholas Plummer, General Counsel of Volition Diagnostics and an officer of VolitionRx Ltd. (VNRX), filed a Form 4.
• The filing reports a transaction on August 1, 2025, involving the disposition of 4,451 shares of common stock.
• These shares were retained by VolitionRx for cancellation to satisfy tax withholding obligations related to the settlement of 16,086 restricted stock units (RSUs).
• The RSUs were awarded to Mr. Plummer in lieu of cash compensation.
• The transaction price for the disposed shares was $0.64 per share.
• Following this transaction, Mr. Plummer beneficially owns 183,846 shares of common stock directly.
• No shares were sold by Mr. Plummer or VolitionRx in this transaction; it was solely for tax withholding.

Sentiment

Score: 7

Explanation: The filing reports a routine, non-sale transaction related to executive compensation (RSU vesting and tax withholding). This is a neutral to slightly positive event as it indicates RSU settlement and aligns management interests, without any negative implications like open market sales.

Positives

• The transaction represents a non-sale disposition of shares solely for tax withholding purposes, indicating the settlement of previously awarded restricted stock units.
• The award of restricted stock units in lieu of cash compensation aligns the officer's interests with long-term shareholder value.

Future Outlook

The filing does not contain forward-looking statements or guidance, as it is a historical report of an insider transaction.

Management Comments

• Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 16,086 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person.
• No shares were sold by the reporting person or VolitionRx in such transaction.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity transaction, specifically related to the vesting of restricted stock units and associated tax withholding. It does not provide broader industry context or trends, but such transactions are common across publicly traded companies as part of executive compensation plans.

Comparison to Industry Standards

• This transaction is a standard practice for settling restricted stock units and covering tax obligations, common across various industries for executive compensation.
• It does not involve a sale by the insider, which is generally viewed more favorably than open market sales.
• Comparable companies often use RSUs as a form of long-term incentive, and the tax withholding process is a standard part of RSU vesting.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a non-sale transaction for tax purposes, but it reflects the ongoing vesting of executive compensation, which aligns management incentives with shareholder value.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction related to the vesting of restricted stock units and tax withholding, not an open market sale. Such transactions are common and do not typically indicate a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. It's a neutral event that confirms the ongoing compensation structure for executives.

Keywords

VolitionRx, VNRX, Form 4, Insider Transaction, Nicholas Plummer, Restricted Stock Units, Tax Withholding, Officer Compensation, Beneficial Ownership